BioSpace News Archive

Genetown

Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company’s Refocused Strategy

Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announced an amendment to its existing financing agreement with Oberland Capital Management LLC.

May 9, 2022
·
5 min read
Policy

Eisai completes rolling submission to the FDA of lecanemab for early Alzheimer’s disease under the accelerated approval pathway

BioArctic AB’s partner Eisai announced that they have completed the rolling submission to the U.S. FDA of a Biologics License Application under the accelerated approval pathway for the investigational anti-amyloid beta protofibril antibody lecanemab, for the treatment of mild cognitive impairment due to Alzheimer’s disease and mild AD with confirmed presence of amyloid pathology in the brain.

May 9, 2022
·
7 min read